VET THERAPEUTICS INC has a total of 25 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FACET BIOTECH CORP, UBIPROTEIN CORP and THERAMAB LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | Japan | 2 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Hansen Genevieve | 21 |
#2 | Genevieve Hansen | 4 |
Publication | Filing date | Title |
---|---|---|
AU2016216708A1 | Monoclonal antibodies | |
AU2014200771A1 | Monoclonal antibodies | |
WO2011109108A1 | Monoclonal antibodies directed to cd20 | |
BR112012022342A2 | cd52 targeted monoclonal antibodies | |
EP2411050A2 | Antibody constant domain regions and uses thereof | |
EP2725037A1 | Monoclonal antibodies binding canine CD20 |